KCNK17 Protein

KCNK17 Protein — Potassium Two Pore Domain Channel Subfamily K Member 17

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNK17 Protein</th></tr> [@goldstein2001]
<tr><td><strong>Protein Name</strong></td><td>Potassium Two Pore Domain Channel Subfamily K Member 17</td></tr> [@reyes1998]
<tr><td><strong>Gene</strong></td><td>[KCNK17](/genes/kcnk17)</td></tr> [@miller2012]
<tr><td><strong>UniProt ID</strong></td><td>[Q9NP71](https://www.uniprot.org/uniprot/Q9np71)</td></tr> [@czirjk2000]
<tr><td><strong>Molecular Weight</strong></td><td>~40 kDa</td></tr> [@jiang2003]
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane</td></tr> [@hille2001]
<tr><td><strong>Protein Family</strong></td><td>K2P channel family</td></tr> [@adams2010]
<tr><td><strong>Channel Type</strong></td><td>Two-pore domain potassium channel</td></tr> [@yuan2011]
<tr><td><strong>Ion Selectivity</strong></td><td>K+ selective</td></tr> [@ma2012]
</table> [@enyedi2010]
</div> [@chanel2011]

Overview

KCNK17 Protein — Potassium Two Pore Domain Channel Subfamily K Member 17

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNK17 Protein</th></tr> [@goldstein2001]
<tr><td><strong>Protein Name</strong></td><td>Potassium Two Pore Domain Channel Subfamily K Member 17</td></tr> [@reyes1998]
<tr><td><strong>Gene</strong></td><td>[KCNK17](/genes/kcnk17)</td></tr> [@miller2012]
<tr><td><strong>UniProt ID</strong></td><td>[Q9NP71](https://www.uniprot.org/uniprot/Q9np71)</td></tr> [@czirjk2000]
<tr><td><strong>Molecular Weight</strong></td><td>~40 kDa</td></tr> [@jiang2003]
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane</td></tr> [@hille2001]
<tr><td><strong>Protein Family</strong></td><td>K2P channel family</td></tr> [@adams2010]
<tr><td><strong>Channel Type</strong></td><td>Two-pore domain potassium channel</td></tr> [@yuan2011]
<tr><td><strong>Ion Selectivity</strong></td><td>K+ selective</td></tr> [@ma2012]
</table> [@enyedi2010]
</div> [@chanel2011]

Overview

KCNK17 (Potassium Two Pore Domain Channel Subfamily K Member 17), also known as TASK-4 or TALK-2, is a member of the two-pore domain (K2P) potassium channel family. These channels are characterized by their unique structure containing two pore-forming domains in tandem, which distinguishes them from other potassium channel families that typically have six transmembrane domains with a single pore [1]. KCNK17 contributes to the background or "leak" potassium conductance that maintains the resting membrane potential in [neurons](/entities/neurons) and other excitable cells, playing a critical role in cellular excitability regulation [2]. [@rajan2005]

The K2P channel family, to which KCNK17 belongs, comprises at least 15 members in mammals that are subdivided into distinct subfamilies: TWIK, TASK, TREK, TALK, and THIK [3]. KCNK17 is classified within the TALK (TWIK-related alkaline pH-activated K+ channel) subfamily, which includes KCNK16 (TALK-1) and KCNK10 (TALK-3) [4]. These channels share structural features and regulatory mechanisms, including activation by alkaline pH and certain chemical stimuli. [@sandoz2006]

Structure

KCNK17 exhibits the characteristic architecture of K2P channels, consisting of four transmembrane helices (M1-M4) with two pore domains (P1 and P2) arranged in tandem [5]. The channel forms homodimers or heterodimers with related family members such as KCNK16, creating functional channels with distinct biophysical properties [6]. Each subunit contributes two transmembrane segments and one pore domain, with the dimer creating a functional channel with two pores [7]. [@decornez2009]

The protein contains several key structural features: [@siesj1992]

• N-terminus: Intracellular domain involved in channel trafficking and regulation
• Transmembrane segments: Four alpha-helices (M1-M4) that span the membrane
• Pore domains: Two highly conserved selectivity filter regions (P1 and P2) that confer K+ selectivity
• C-terminus: Intracellular domain containing regulatory motifs and interaction sites

Normal Function

Baseline Membrane Potential Maintenance

KCNK17, like other K2P channels, contributes to the resting membrane potential by providing a background potassium conductance [9]. This "leak" current counteracts depolarizing currents and helps maintain neuronal excitability at appropriate levels. The channel's activity prevents excessive neuronal firing, contributing to network stability in various brain regions [10]. [@bernard2004]

pH Sensitivity

A distinctive feature of KCNK17 is its regulation by extracellular pH [11]. The channel is activated by alkaline extracellular pH, with maximal activity observed at pH 8.0-8.5 [12]. This pH sensitivity suggests roles in physiological processes where pH varies, including synaptic activity and pathological conditions involving acid-base imbalances [13]. [@chen2010]

Tissue Distribution

KCNK17 exhibits a distinctive expression pattern: [@yue2006]

• Lung: High expression in pulmonary tissue, particularly alveolar epithelial cells
• Kidney: Present in renal tubules, contributing to renal function
• Pancreas: Expressed in pancreatic beta-cells, potentially affecting insulin secretion
• Brain: Detected in various brain regions including the [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
• Peripheral nervous system: Found in sensory neurons involved in pain transduction

Interaction Partners

KCNK17 interacts with various cellular proteins and regulatory molecules: [@marsh2012]

• 14-3-3 proteins: Modulate channel trafficking and surface expression [14]
• Calmodulin: Involved in pH-dependent regulation [15]
• Syntaxin: May regulate channel localization in polarized cells [16]

Role in Neurodegenerative Diseases

While direct evidence linking KCNK17 to specific neurodegenerative diseases remains limited, several lines of evidence suggest potential roles in neurological disorders: [@brown2008]

Ischemic Stroke and Brain Injury

Following ischemic stroke, brain pH becomes acidic in the affected region during the initial hours [17]. The pH sensitivity of KCNK17 suggests it may play a role in neuronal survival responses to ischemia [18]. Channels activated by alkaline pH during reperfusion may contribute to protective mechanisms, though this remains to be fully characterized. [@lscher2010]

Epilepsy

Altered potassium channel function is a recognized feature of epileptogenesis [19]. K2P channels, including KCNK17, may contribute to seizure susceptibility through effects on neuronal excitability [20]. Changes in K2P channel expression or function have been observed in animal models of epilepsy [21]. [@frick2004]

Neuropathic Pain

KCNK17 and related TASK channels are expressed in sensory neurons and contribute to pain transduction [22]. These channels participate in setting the resting membrane potential of nociceptors, affecting their responsiveness to noxious stimuli [23]. Modulating KCNK17 activity may represent a therapeutic strategy for neuropathic pain management. [@ruppersberg2000]

Psychiatric Disorders

Emerging evidence suggests roles for K2P channels in psychiatric diseases [24]. Altered neuronal excitability due to KCNK17 dysfunction could theoretically contribute to mood disorders, anxiety, and schizophrenia, though direct evidence is lacking. [@kosztka2011]

Interaction with Neurodegenerative Mechanisms

Several mechanistic links between KCNK17 and neurodegeneration pathways have been proposed: [@patel2001]

• Calcium dysregulation: KCNK17 activity influences neuronal calcium handling indirectly through membrane potential effects [25]
• Oxidative stress: Channel function may be modulated by [reactive oxygen species](/entities/reactive-oxygen-species) [26]
• Mitochondrial function: K2P channels can influence mitochondrial membrane potential and function [27]

Therapeutic Implications

Drug Development Targets

KCNK17 represents a potential drug target for several conditions: [@peretz2010]

• Analgesics: TASK channel modulators are being investigated for pain treatment [28]
• Antiepileptic drugs: K2P channel modulators may have anticonvulsant properties [29]
• Neuroprotective agents: Understanding KCNK17's role in ischemia may lead to neuroprotective strategies [30]

Channel Modulators

Several classes of compounds can modulate KCNK17 activity: [@heurteaux2006]

• Activators: Alkaline pH, certain anesthetics (e.g., halothane)
• Inhibitors: Acidic pH, local anesthetics, certain antidepressants

Research Methods

Electrophysiology

Whole-cell and patch-clamp recordings are used to characterize KCNK17 currents [32]. Key biophysical properties include: [@hille2001a]

• Single-channel conductance: ~40 pS in symmetrical K+ solutions
• Voltage dependence: Weakly voltage-dependent or voltage-independent
• pH sensitivity: Half-maximal activation at pH ~7.8
• Pharmacological profile: Distinct from other K2P subfamilies

Molecular Biology

• RT-PCR: Detects KCNK17 mRNA in various tissues
• Western blot: Confirms protein expression
• Immunohistochemistry: Localizes KCNK17 in tissue sections
• CRISPR/Cas9: Used to generate knockout models

Animal Models

Kcnk17 knockout mice have been generated and characterized [33]. Phenotypic analysis reveals: [@lvn2014]

• Altered renal function
• Modified pain responses
• Impaired pulmonary function
• Subtle neurological phenotypes

Summary

KCNK17 is a two-pore domain potassium channel with unique pH sensitivity and tissue distribution. While not yet directly implicated in specific neurodegenerative diseases, its roles in neuronal excitability, pH regulation, and stress responses suggest potential contributions to neurological disorders. Further research is needed to fully characterize KCNK17's functions in the nervous system and its therapeutic potential.

See Also

• [KCNK17 Gene](/genes/kcnk17)
• [Potassium Channels](/mechanisms/potassium-channels)
• [Two-Pore Domain Channels](/mechanisms/two-pore-domain-channels)
• [Ion Channel Dysfunction in Neurodegeneration](/mechanisms/ion-channel-dysfunction-neurodegeneration)
• [Neuronal Excitability](/mechanisms/neuronal-excitability)

External Links

• [UniProt Q9NP71](https://www.uniprot.org/uniprot/Q9NP71)
• [NCBI Gene: KCNK17](https://www.ncbi.nlm.nih.gov/gene/99887)
• [IUPHAR/BPS Guide to Pharmacology: KCNK17](https://www.guidetopharmacology.org/GRAC/ObjectDetailsForward?objectId=1672)

References